Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME   >  CORPORATE INFO > MF HOLDINGS
MF Holdings      
Mankind Pharma Ltd.
BSE Code 543904
ISIN Demat INE634S01028
Book Value 363.64
NSE Code MANKIND
Dividend Yield % 0.00
Market Cap 1059200.20
P/E 58.39
EPS 43.95
Face Value 1  
Scheme NameMarket Val (In Crs.)AUM(In Crs.)Hold Percentage
SBI Large Cap Fund-Reg(G) 651.18 53959.08 1.21
HDFC Large Cap Fund(G) 426.43 38905.12 1.10
Axis ELSS Tax Saver Fund-Reg(G) 308.74 36257.53 0.85
SBI Contra Fund-Reg(IDCW) 308.08 47389.62 0.65
SBI Midcap Fund-Reg(G) 293.66 23269 1.26
Invesco India Contra Fund(G) 255.89 19257.4 1.33
Axis Flexi Cap Fund-Reg(G) 249.71 13316.5 1.88
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G) 240.46 5727.59 4.20
Axis Focused Fund-Reg(G) 229.26 13024.65 1.76
PGIM India Midcap Fund-Reg(G) 214.12 11640.22 1.84
Motilal Oswal Midcap Fund-Reg(G) 213.09 33053.13 0.64
Canara Rob Large Cap Fund-Reg(G) 210.61 16617.33 1.27
Kotak Small Cap Fund(G) 184.59 18031.02 1.02
Nippon India Pharma Fund(G) 175.72 8569.15 2.05
Canara Rob Flexi Cap Fund-Reg(G) 159.49 13588.06 1.17
Invesco India Focused Fund-Reg(G) 131.01 4153.39 3.15
SBI Healthcare Opp Fund-Reg(IDCW) 129.91 3849.24 3.37
Sundaram Mid Cap Fund-Reg(G) 126.49 12818.1 0.99
Nippon India ELSS Tax Saver Fund(G) 122.93 15623.15 0.79
Nippon India Flexi Cap Fund-Reg(G) 122.58 9299.75 1.32
Page 1 of 9
Prev || Next
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.